Drugs / OmniHIB
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00729001 Background | Nov 2000 → Sep 2002 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OmniHIB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00729001 ↗ |
| Route | Intramuscular | “Three-dose intramuscular injection (US subjects only)” NCT00729001 ↗ |